The Reply - 31/01/18
Doi : 10.1016/j.amjmed.2017.10.022
Jennifer N. Goldstein, MD, MSc a, b, Zugui Zhang, PhD b, J. Sanford Schwartz, MD c, LeRoi S. Hicks, MD, MPH a, b
a Department of Medicine, Christiana Care Health System, Newark, Del
b Christiana Care Health System, The Value Institute, Newark, Del
c Division of General Internal Medicine, University of Pennsylvania, Philadelphia, Pa
Le texte complet de cet article est disponible en PDF.
| Funding: JSS has received consultancy fees from Bayer, Pfizer, Takeda, The Blue Cross Blue Shield Association, and the Agency for Healthcare Research and Quality, unrelated to the content of this study. |
|
| Conflicts of Interest: None. |
|
| Authorship: All authors had access to the data and played a role in writing this manuscript. |
|
| The data from this analysis were presented at the 2017 Society of General Internal Medicine Annual Meeting and is not under consideration for publication elsewhere. |
© 2018
Elsevier Inc. Tous droits réservés.
Vol 131 - N° 2
P. e69 - février 2018 Retour au numéro
Article précédent
- Impact of Observation Hospitalizations on Low-Income Medicare Beneficiaries
- Ann M. Sheehy, Leslie Thompson, Bradley Flansbaum
- Migraine Headache and Long-Term Cardiovascular Outcomes: Methodological Issues
- Erfan Ayubi, Saeid Safiri
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?